Seeing Is Believing
Currently out of the existing stock ratings of Marc Frahm, 3 are a BUY (37.5%), 5 are a HOLD (62.5%).
Analyst Marc Frahm works at TD COWEN with a stock forecast success ratio of 53.33% fulfilled within 48 days on average. Previously, Marc Frahm worked at COWEN.
Marc Frahm’s has documented 16 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TBPH, Theravance Biopharma at 08-Nov-2023.
Analyst best performing recommendations are on TBPH (THERAVANCE BIOPHARMA).
The best stock recommendation documented was for TBPH (THERAVANCE BIOPHARMA) at 9/15/2021. The price target of $8 was fulfilled within 23 days with a profit of $1.23 (18.17%) receiving and performance score of 7.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
10
$0.99 (10.99%)
9
4 months 21 days ago
3/5 (60%)
$-0.25 (-2.44%)
96
Buy
20
$10.99 (121.98%)
20
7 months 21 days ago
3/10 (30%)
$10.26 (105.34%)
35
Buy
14
$4.99 (55.38%)
12
1 years 4 months 12 days ago
0/2 (0%)
$2.66 (23.46%)
Sell
10
$0.99 (10.99%)
10
1 years 8 months 4 days ago
2/8 (25%)
$0.76 (8.23%)
70
Buy
12
$2.99 (33.19%)
10
1 years 10 months 6 days ago
3/8 (37.5%)
$2.6 (27.66%)
85
Which stock is Marc Frahm is most bullish on?
What Year was the first public recommendation made by Marc Frahm?